Navigation Links
Human Genome Sciences Announces Positive Results in Second of Two Phase 3 Trials of Albuferon(R) in Chronic Hepatitis C
Date:3/9/2009

9 days. Research has shown that genetic fusion of therapeutic proteins to human albumin decreases clearance and prolongs the half-life of the therapeutic proteins.

Albuferon is being developed by HGS and Novartis for the treatment of chronic hepatitis C under an exclusive worldwide co-development and commercialization agreement entered into in June 2006. HGS and Novartis will co-commercialize Albuferon in the United States and will share clinical development costs, U.S. commercialization costs and U.S. profits equally. Novartis will be responsible for commercialization in the rest of the world and will pay HGS a royalty on those sales. Clinical development, commercial milestone and other payments to HGS could total as much as $507.5 million, including $132.5 million received to date.

About Hepatitis C

Hepatitis C is an inflammation of the liver caused by the hepatitis C virus. It is estimated that as many as 170 million people worldwide are infected with hepatitis C virus. This includes nearly four million people in the United States. When detectable levels of HCV persist in the blood for at least six months, a person is diagnosed with chronic hepatitis C. Hepatitis C virus can cause serious liver disease, leading to cirrhosis, primary liver cancer and even death. Patients infected with the genotype 1 hepatitis C virus account for approximately 75% of the chronic hepatitis C patients in the U.S.

Conference Call

HGS management will hold a conference call to discuss this announcement today at 8:15 AM Eastern. Investors may listen to the call by dialing 888-203-1112 or 719-457-0820, passcode 4076361, five to 10 minutes before the start of the call. A replay of the conference call will be available within a few hours after the call ends. Investors may listen to the replay by dialing 888-203-1112 or 719-457-0820, confirmation code 4076361. A replay of the conf
'/>"/>

SOURCE Human Genome Sciences, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. Drug Development Program Started Based on CAP(R) Human Cell Line
2. Human Genome Sciences Announces Fourth-Quarter and Full-Year 2008 Financial Results and Key Developments
3. IlluminOss Medical Announces First Human Case Utilizing a Unique, New, Minimally Invasive Technology for Fracture Repair is Performed at Medical Hospital del Trabajadar in Santiago, Chile
4. GeoVax Starts Injections for Phase 2a Human HIV/AIDS Vaccine Trial in USA
5. FDA Grants Priority Review of a Supplemental Biologics License Application for Cinryze(TM) C1 Inhibitor (Human) as Treatment for Acute Attacks of Hereditary Angioedema (HAE)
6. Cloned Human Embryos Successfully Reprogrammed Using Human - But Not Animal - Eggs
7. Human Genome Sciences Begins Delivery of First-in-Class Anthrax Treatment to U.S. Strategic National Stockpile
8. Mardil Inc. Advances Its Novel Cardiac Device to First-In-Human Trials for Mitral Valve Regurgitation
9. Modigene Announces Positive Results of Pilot Toxicity Study of Its Long-Acting Human Growth Hormone hGH-CTP
10. Human Genome Sciences Reports Substantial Progress Toward Commercialization and Announces 2009 Goals at JPMorgan Healthcare Conference
11. Cequent to Present First Proof of Activity of an Oral RNAi Drug in Non-Human Primates at February Keystone Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/5/2015)... --Research and Markets ( http://www.researchandmarkets.com/research/vwvddw/therapeutic_drug ) ... report "Therapeutic Drug Monitoring - Technologies, Markets, ... This report deals with therapeutic drug monitoring, ... care by monitoring drug levels in the blood ... improving outcome. TDM is viewed as a component ...
(Date:3/5/2015)... -- Mr Minoru Yoshizumi , President ... , is pleased to announce the release of ... at the European Radiology Congress (ECR). Delegates will have ... Hitachi Medical Systems booth 323, Expo C. ...      (Photo: http://photos.prnewswire.com/prnh/20150305/732754-b ) , , ...
(Date:3/5/2015)... Minn., March 5, 2015  MGC Diagnostics Corporation ... technology company, today reported financial results for the ... , 2015 first quarter domestic equipment, supplies and ... to $3.7 million in the 2014 first quarter.  ... accounts, or $338,000 in revenue, compared to 14 ...
Breaking Medicine Technology:Global Therapeutic Drug Monitoring Report 2015 - Technologies, Markets, and Companies Analysis 2014-2024 2Hitachi Aloka Medical, Ltd. Introduces EggQus AOS 100E - a Compact and Lightweight Ultrasound Bone Densitometry System 2Hitachi Aloka Medical, Ltd. Introduces EggQus AOS 100E - a Compact and Lightweight Ultrasound Bone Densitometry System 3MGC Diagnostics Corporation Reports Fiscal 2015 First Quarter Results 2MGC Diagnostics Corporation Reports Fiscal 2015 First Quarter Results 3MGC Diagnostics Corporation Reports Fiscal 2015 First Quarter Results 4MGC Diagnostics Corporation Reports Fiscal 2015 First Quarter Results 5MGC Diagnostics Corporation Reports Fiscal 2015 First Quarter Results 6MGC Diagnostics Corporation Reports Fiscal 2015 First Quarter Results 7MGC Diagnostics Corporation Reports Fiscal 2015 First Quarter Results 8MGC Diagnostics Corporation Reports Fiscal 2015 First Quarter Results 9MGC Diagnostics Corporation Reports Fiscal 2015 First Quarter Results 10MGC Diagnostics Corporation Reports Fiscal 2015 First Quarter Results 11MGC Diagnostics Corporation Reports Fiscal 2015 First Quarter Results 12
... Calif. , June 4 Derycz Scientific, Inc. ... fresh way of facilitating the flow of information from content ... Reprints Desk, an award-winning provider of information services and content ... events: Digital Pharma West , being held in ...
... VIEW, Calif. , June 3 Alexza Pharmaceuticals, Inc. (Nasdaq: ... will present during the Jefferies 2010 Global Life Sciences Conference.  The Alexza ... pm ET .  The presentation will be webcast from the Grand Hyatt Hotel ... , , ...
Cached Medicine Technology:Derycz Scientific to Exhibit at Digital Pharma West and Digital Pharma East 2Derycz Scientific to Exhibit at Digital Pharma West and Digital Pharma East 3Derycz Scientific to Exhibit at Digital Pharma West and Digital Pharma East 4Alexza Pharmaceuticals to Present at Jefferies 2010 Global Life Sciences Conference 2Alexza Pharmaceuticals to Present at Jefferies 2010 Global Life Sciences Conference 3
(Date:3/5/2015)... (PRWEB) March 05, 2015 As ... Assistants’ (AAPA) review of Clearstream, LLC ’s ... that Clearstream’s MediDefense line of products—led by their ... AAPA’s Affinity Partner Program. , The AAPA—which represents ... across all medical and surgical specialties in the ...
(Date:3/5/2015)... Menlo Park, California (PRWEB) March 05, 2015 ... Psychopharmacology (JCAP) last week released a special ... experts in the field of PANDAS (Pediatric Autoimmune ... Acute-onset Neuropsychiatric Syndromes), an autoimmune reaction triggered by ... and lyme, which result in inflammation of the ...
(Date:3/5/2015)... Florida (PRWEB) March 05, 2015 ... organization which provides vascular, echocardiogram and NCV ... F.A.C.C. as the Chief Medical Officer. Dr. Artel will ... the development of the WimbledonMED program and the continued ... been passionate about working with Wimbledon Health Partners as ...
(Date:3/5/2015)... March 5, 2015 – As National Patient Safety ... 2015), children’s hospitals around the country are affirming the ... as safe as possible for their children. , A ... Patient Safety (SPS) and the Children’s Hospital Association—are collaborating ... visiting the hospital with their child. , “SPS ...
(Date:3/5/2015)... MTC 5-day Fundamental Implantology Course has been developed by ... dental disciplines, to offer implant placement treatment to their ... wanted this course to be a truly empowering experience ... the lecturers and the sheer energy and enthusiasm of ... aims." , Unlike large-scale training operations, the MTC ...
Breaking Medicine News(10 mins):Health News:Clearstream’s Line of MediDefense Antimicrobial Products Scores Affinity Partnership With American Academy of Physician Assistants (AAPA) 2Health News:Clearstream’s Line of MediDefense Antimicrobial Products Scores Affinity Partnership With American Academy of Physician Assistants (AAPA) 3Health News:Clearstream’s Line of MediDefense Antimicrobial Products Scores Affinity Partnership With American Academy of Physician Assistants (AAPA) 4Health News:Controversial Childhood Illness PANDAS the Focus of a Special Medical Journal Issue 2Health News:Controversial Childhood Illness PANDAS the Focus of a Special Medical Journal Issue 3Health News:Wimbledon Health Partners Appoints Chief Medical Officer to Attain Medicare Market Share 2Health News:Wimbledon Health Partners Appoints Chief Medical Officer to Attain Medicare Market Share 3Health News:Children’s Hospitals Offer Safety Tips for Patient Families During National Patient Safety Awareness Week 2Health News:Children’s Hospitals Offer Safety Tips for Patient Families During National Patient Safety Awareness Week 3Health News:Children’s Hospitals Offer Safety Tips for Patient Families During National Patient Safety Awareness Week 4Health News:MIS Global Training Center (MTC) Launches its Fundamental Implantology Course for Doctors - with a Difference 2
... in easy-to-use pump provides hours of itch relief for active women ... the feminine hygiene product market, Vagisil(R) has announced the introduction of ... -- a fast-absorbing creme that provides quick and long-lasting relief ... skin. Perfect for women on the go, Vagisil Satin ...
... Coverage Can Provide an Unrestricted Financial Lifeline for ... The Guardian Life Insurance Company of America ... and asks families, business owners, benefits decision makers ... this devastating illness can have on a person,s ...
... Help Arthritis Sufferers Manage Inflammation and Stiffness LANSING, ... adults currently suffer from arthritis - and as the ... May has been deemed National Arthritis Month to generate ... associated symptoms. For many with arthritis, one step in ...
... (NYSE: DVA ) announced that the United States ... informed the company that it has completed its investigation without ... first issued a formal subpoena in October 2004 and fully ... the company, no fines were assessed and no mandatory policy ...
... Olivia Greets, a live, 24-hour, avatar-based virtual receptionist ... healthcare market. The Olivia Greets Patient Check-in Solution ... to streamline the check-in process similar to how ... to use. The Olivia Greets solution provides patients ...
... (May 4, 2009) New research published in the ... College of Surgeons shows that dramatic disparities in ... regardless of the age at which they are diagnosed, ... status. The study represents the largest population-based analysis of ...
Cached Medicine News:Health News:Feminine Hygiene Brand Leader Helps Women Restore Their Feminine Self With Launch of Vagisil Satin(TM) 2Health News:Guardian Highlights Significance of Critical Illness Insurance During National Stroke Awareness Month 2Health News:Guardian Highlights Significance of Critical Illness Insurance During National Stroke Awareness Month 3Health News:Guardian Highlights Significance of Critical Illness Insurance During National Stroke Awareness Month 4Health News:Experts Recommend Cherries For Pain Relief From Arthritis 2Health News:Experts Recommend Cherries For Pain Relief From Arthritis 3Health News:New Olivia Greets Patient Check-in Solution Streamlines Healthcare Operations 2Health News:African-American women still have poorer breast cancer outcomes 2Health News:African-American women still have poorer breast cancer outcomes 3
... Established in 1979, ... testing services in the ... Wellness, Insurance, Clinical Trials ... under one roof at ...
Focus Diagnostics Reference Laboratory is known for quality infectious disease and autoimmune testing services. We offer over 1200 tests and panels and are continually adding new tests to our menu....
Millenova Immunology Laboratories is a reference laboratory dedicated to the diagnosis of immunologic causes of reproductive failure, infertility and recurrent pregnancy loss....
PhenoPath Laboratories provides screening, diagnostic, and prognostic testing services to hospitals, physician offices, surgery centers, biopharmaceutical companies and research institutions nationwi...
Medicine Products: